Poolbeg Pharma (POLB)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 7.60p
   
  • Change Today:
      0.000p
  • 52 Week High: 14.90p
  • 52 Week Low: 7.40p
  • Currency: UK Pounds
  • Shares Issued: 500.00m
  • Volume: 972,957
  • Market Cap: £38.00m
  • Beta: 0.80

Regulatory News

POLB 001 Patent Granted in United States 20-Nov-2024 07:00 RNS
Interim results for the six months to 30 June 2024 18-Sep-2024 07:00 RNS
Holding(s) in Company 12-Aug-2024 13:28 RNS
Voluntary Delisting from OTCQB Market 26-Jul-2024 07:00 RNS
Notification of Major Holdings 10-Jul-2024 07:00 RNS
Change of Registered Address 02-Jul-2024 07:00 RNS
Result of AGM 17-Jun-2024 08:38 RNS
Annual Report & AGM Notice 09-May-2024 07:00 RNS
Significant POLB 001 Patent Granted in USA 01-May-2024 07:00 RNS
Appointment of Joint Broker 30-Apr-2024 07:02 RNS
Option Agreement to Acquire Orphan Drug Candidate 30-Apr-2024 07:01 RNS
Results for the year ended 31 December 2023 30-Apr-2024 07:00 RNS
TR-1: Notification of major holdings 29-Apr-2024 07:00 RNS
Director/PDMR Shareholding 22-Feb-2024 07:00 RNS
Director Share Purchase 19-Feb-2024 13:42 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Poolbeg Pharma Market Data

Currency UK Pounds
Share Price 7.60p
Change Today 0.000p
% Change 0.00 %
52 Week High 14.90p
52 Week Low 7.40p
Volume 972,957
Shares Issued 500.00m
Market Cap £38.00m
Beta 0.80

Poolbeg Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
61.63% below the market average61.63% below the market average61.63% below the market average61.63% below the market average61.63% below the market average
36% below the sector average36% below the sector average36% below the sector average36% below the sector average36% below the sector average
Price Trend
59.16% below the market average59.16% below the market average59.16% below the market average59.16% below the market average59.16% below the market average
18.37% below the sector average18.37% below the sector average18.37% below the sector average18.37% below the sector average18.37% below the sector average
Income Not Available
Growth Not Available

Poolbeg Pharma Dividends

No dividends found

Trades for 21-Nov-2024

Time Volume / Share Price
16:37 30,000 @ 7.60p
16:03 30,000 @ 7.60p
16:03 30,000 @ 7.60p
15:59 6,443 @ 7.76p
15:59 300 @ 7.75p

Poolbeg Pharma Key Personnel

CEO Jeremy Skillington
CFO Ian O’Connel

Top of Page